Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Accriva Diagnostics logo — Empowering healthcare with innovative near-patient testing a...

Accriva Diagnostics

Empowering healthcare with innovative near-patient testing and diagnostic solutions since 2009.

Founded 2010 1001-5000 employees Venture round Total: $15.47M Health Care, Medical Devices

General Information

Company Name Accriva Diagnostics
Founded Year 2010
Employees 1001-5000
Industries Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Accriva Diagnostics. To contact Accriva Diagnostics, visit accriva.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Accriva Diagnostics compare?

A PDF of Accriva Diagnostics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Accriva Diagnostics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Accriva Diagnostics

Accriva Diagnostics, a company specializing in near-patient testing and advanced diagnostic solutions, has been empowering healthcare since 2009. The company's product line includes compact immunoassay analyzers, hematology analyzers, high-sensitivity immunoassay analyzers, and clinical chemistry analyzers. Headquartered in San Diego, California, Accriva Diagnostics has made significant strides in the Health Care and Medical Devices industries. In March 10, 2015, the company secured a noteworthy $15.47M in a Venture Round investment from prominent investors Warburg Pincus and Trog Hawley Capital. This injection of capital serves as a testament to the potential and promise that these investors see in Accriva Diagnostics, highlighting their confidence in the company's vision and products. With such substantial backing, Accriva Diagnostics is well-positioned to continue making valuable contributions to the healthcare industry with their innovative solutions.

Business keywords: Healthcare Diagnostics, Near-Patient Testing, Diagnostic Solutions, Immunoassay Analyzers, Hematology Analyzers, Clinical Chemistry Analyzers, San Diego, Point-of-Care Diagnostics, Cardiovascular, Platelet Reactivity Testing, Coagulation Monitoring

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $15.47M 2
Warburg Pincus Trog Hawley Capital
Warburg Pincus, Trog Hawley Capital
10 Mar 2015
Venture Round Undisclosed 1
Bay City Capital
Bay City Capital
01 Mar 2009

Accriva Diagnostics Alternatives & Competitors

View All Alternatives
Accriva Diagnostics vs
Xagenic
Xagenic

Empowering clinicians with rapid, near-patient molecular testing for improved patient care and reduc...

Series B
Biotechnology, Health Care
Accriva Diagnostics vs
Truvian
Truvian United States

blood testing anyone. anywhere.

Venture round
108 employees
Biotechnology, Health Care
Accriva Diagnostics vs
ARKRAY USA
ARKRAY USA United States

Your Diabetes Health Ally

147 employees
Health Care, Medical Devices
View all alternatives

FAQ About Accriva Diagnostics

Empowering healthcare with innovative near-patient testing and diagnostic solutions since 2009.
Accriva Diagnostics was founded in 2010.
Accriva Diagnostics operates in Health Care and Medical Devices. Its work centres on Healthcare Diagnostics, Near-Patient Testing, Diagnostic Solutions and Immunoassay Analyzers.
Accriva Diagnostics has approximately 1001-5000 employees.
Accriva Diagnostics has completed 2 funding rounds, raising a total of $15.47M. The latest funding stage is Venture round.
Top alternatives and competitors to Accriva Diagnostics include Xagenic, Truvian, ARKRAY USA, Clinical Diagnostic Solutions, Nanjing Poclight Biotechnology Co., Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Accriva Diagnostics and Xagenic are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Accriva Diagnostics, https://bouncewatch.com/company/accriva-diagnostics-1, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes